Rolaids Ultra Strength 1200 Tablet, Chewable
NDC Package 84126-322-72
Package Information
Rolaids Ultra Strength 1200 (calcium carbonate, magnesium hydroxide) tablets is adults and children 12 years and over: 2-3 chewable tablets as symptoms occur, or as directed by a doctor. This formulation utilizes a tablet, chewable delivery system. Marketed by The Procter & Gamble Manufacturing Company, this product is identified by NDC 84126-322 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 1438105 - calcium carbonate 1000 MG / magnesium hydroxide 200 MG Chewable Tablet
- RxCUI: 1438107 - Rolaids ULTRA 1000 MG / 200 MG Chewable Tablet, Reformulated Aug 2006
- RxCUI: 1438107 - calcium carbonate 1000 MG / magnesium hydroxide 200 MG Chewable Tablet [Rolaids Reformulated Aug 2006]
- RxCUI: 1438107 - Rolaids Ultra (calcium carbonate 1000 MG / magnesium hydroxide 200 MG) Chewable Tablet, Reformulated Aug 2006
Clinical Specifications
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 84126 - The Procter & Gamble Manufacturing Company
- 84126-322 - Rolaids Ultra Strength 1200
- 84126-322-72 - 72 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC
- 84126-322 - Rolaids Ultra Strength 1200
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (84126-322). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84126-322-72 identifies a specific commercial package of 72 tablet, chewable in 1 bottle, plastic of Rolaids Ultra Strength 1200, a human over the counter drug labeled by The Procter & Gamble Manufacturing Company. This tablet, chewable is formulated for oral use and contains calcium carbonate; magnesium hydroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Procter & Gamble Manufacturing Company on December 06, 2024. The current certification is valid through December 31, 2026.
How is this The Procter & Gamble Manufacturing Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84126032272. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.